A lot of the Canadian cannabis LPs shunned the U.S.
This year hasn’t been a great one for medical cannabis provider Tilray (TLRY), to say the least. Tilray stock has been killed over …
The greatest challenge for Tilray (TLRY) is its inability to live up to the unwarranted hype that accompanied the aftermath of its IPO, …
Let’s get straight to the point. The only reason to own Tilray (TLRY) stock is whether the business opportunities justifies the rich stock …
Tilray (TLRY) recently announced its biggest shareholder Privateer has signed a non-binding letter of intent to increase the length of its lockup period. …
Over the past two years, the cannabis sector has seen massive volatility, even in some of the largest cap companies which are usually …
Despite the very strong gains in cannabis stocks, there were also several sharp sell-offs lately that caught investors off guard. Much of that …
The Tilray (TLRY) Q1’19 results are the epitome of our 2019 investment thesis of avoiding the large Canadian cannabis stocks. The company generated …
Tilray (TLRY) stock continues to trend lower, as the company’s market position is slipping in Canada with approximately 8% market share, and production …
The world needs weed — and for marijuana products manufacturer Tilray (TLRY), that’s both a problem and a source of potential profit. Last …